Back to newsCrane NXT, Co. <CXT.N>: Jefferies initiates coverage with buy rating; target price $60CCXT•2026-09-22Related NewsVViking Therapeutics reports VK2735 maintenance trial keeps up to 97% of weight loss with every-other-week dosing
CXT•CXT•CXT•CXT•
